How soon does hair greying revert upon vit d and b12 supplementation

Reading File
Finding Sources
Searching PubMed

hair graying AND vitamin B12

Searching the Web

hair graying vitamin B12 vitamin D supplementation reversal evidence

There is no reliable timeline, because vitamin D or B12 supplements usually do not turn already-grey hair back to its original color.
  • If you have a confirmed B12 deficiency contributing to premature greying, treating it may help slow further greying and, rarely, new hair growth can appear darker. Any visible change would need to wait for a new hair-growth cycle, so expect at least 3 to 6 months, not days or weeks.
  • Evidence for vitamin D supplementation reversing grey hair is weak. Correcting deficiency is reasonable for overall health, but repigmentation should not be expected.
  • Existing grey hair shafts are already formed and cannot biologically regain pigment. A change, if it occurs, shows at the roots as newly growing hair.
Most greying is genetic and age-related. Dermatology texts describe it as reduced melanocyte and pigment-producing activity in the hair follicle, not simply a vitamin shortage. Vitamin B12 deficiency is associated with premature greying, but reports of reversal after replacement are mostly anecdotal and high-quality trials are lacking. A recent review likewise found no conclusive evidence that supplements reliably reverse established grey hair, though deficiencies should be corrected (review of hair vitamins/minerals).
If your greying began unusually early or progressed quickly, ask a clinician about confirming the cause rather than supplementing blindly: CBC, serum B12 with confirmatory testing if borderline, folate, ferritin/iron studies, and thyroid tests are often considered. A normal B12 level after taking supplements does not necessarily show whether deficiency was the cause.

Tranexamic acid vs azaleic acid function

Reading File
Finding Sources
Finding Sources
Searching PubMed

melasma tranexamic acid azelaic acid

Searching the Web

tranexamic acid azelaic acid topical skin mechanism melasma acne dermatology

Tranexamic acid vs azelaic acid for skin

FeatureTranexamic acid (TXA)Azelaic acid
Main functionReduces excess pigment formation, especially in melasmaTreats acne, rosacea, post-acne marks, and mild melasma
How it worksInhibits plasmin-related inflammatory and UV-triggered pathways that stimulate melanocytes to make pigmentAntibacterial, anti-inflammatory, normalizes clogged-pore formation, and reduces excess pigment production
Best useStubborn, patchy facial hyperpigmentation, particularly melasmaAcne-prone skin with dark marks, rosacea redness/bumps, or uneven tone
Common formsTopical serum/cream, procedures, or oral tablets prescribed off-labelTopical 10% OTC in some countries; 15% to 20% prescription products
Effect on acneNot an acne treatmentHelps inflammatory acne and comedones
Effect on rosaceaNot a standard rosacea treatmentEstablished treatment for rosacea
Key adverse effectsTopical: possible irritation. Oral: possible blood-clot risk, so only clinician-supervisedStinging, itch, dryness, or temporary irritation, especially early on
Practical distinction:
  • Choose azelaic acid if you have acne, rosacea, acne-related dark spots, or sensitive skin with pigmentation.
  • Tranexamic acid is more specifically targeted at melasma, often as an add-on when sunscreen and other pigment treatments are insufficient.
Both can help pigmentation, but neither replaces strict daily broad-spectrum SPF 30+, ideally tinted with iron oxides for melasma. Melasma commonly relapses without photoprotection. Dermatology references list TXA as an off-label melasma treatment and describe azelaic acid as useful for acne, rosacea, melasma, and post-inflammatory hyperpigmentation. Recent reviews support TXA for melasma, though treatment regimens differ (2024 systematic review and meta-analysis).
Do not start oral tranexamic acid without medical review, especially if you have a history of blood clots, thrombophilia, migraine with aura, smoke, use estrogen-containing contraception, are pregnant/postpartum, or have significant clot-risk factors.
This is a shared conversation. Sign in to Orris to start your own chat.